acetylcysteine has been researched along with Thalassemias in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Khamseekaew, J; Kumfu, S; Siri-Angkul, N; Sumneang, N | 1 |
| Chattipakorn, N; Chattipakorn, SC; Pattanakuhar, S; Phrommintikul, A; Srichairattanakool, S; Tantiworawit, A | 1 |
| Fibach, E; Freikman, I; Ringel, I | 1 |
| Amer, J; Fibach, E; Goldfarb, A | 1 |
| Adamsky, K; Amariglio, N; Breda, L; Cabantchik, ZI; Rachmilewitz, EA; Rechavi, G; Rivella, S; Weizer-Stern, O | 1 |
| Arapakis, G; Gardikas, C; Kirkou, K; Stathakis, N | 1 |
1 review(s) available for acetylcysteine and Thalassemias
| Article | Year |
|---|---|
Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
Topics: Acetylcysteine; Animals; Antimicrobial Cationic Peptides; Antioxidants; Bone Marrow; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Therapy, Combination; Erythrocytes; Gene Expression Regulation; Genetic Therapy; Hepcidins; Humans; Intestinal Absorption; Iron; Iron Chelating Agents; Iron, Dietary; Liver Neoplasms; Mice; Oxidants; Oxidative Stress; Thalassemia; Vitamin E | 2005 |
1 trial(s) available for acetylcysteine and Thalassemias
| Article | Year |
|---|---|
N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial.
Topics: Acetylcysteine; Adult; Cardiac Imaging Techniques; Dinoprost; Echocardiography; Female; Heart Rate; Humans; Interleukin-10; Magnetic Resonance Imaging; Male; Oxidative Stress; Thalassemia; Tumor Necrosis Factor-alpha | 2020 |
4 other study(ies) available for acetylcysteine and Thalassemias
| Article | Year |
|---|---|
Combined iron chelator with N-acetylcysteine exerts the greatest effect on improving cardiac calcium homeostasis in iron-overloaded thalassemic mice.
Topics: Acetylcysteine; Animals; Calcium; Deferiprone; Heart; Homeostasis; Iron Chelating Agents; Iron Overload; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Thalassemia; Ventricular Function, Left | 2019 |
Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Calcimycin; Calcium; Cholesterol; Erythrocyte Membrane; Flow Cytometry; Humans; Ionophores; Membrane Lipids; Nuclear Magnetic Resonance, Biomolecular; Osmotic Pressure; Oxidants; Oxidative Stress; Phagocytosis; Phosphatidylserines; Phospholipids; tert-Butylhydroperoxide; Thalassemia | 2011 |
Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells.
Topics: Acetylcysteine; Antioxidants; Case-Control Studies; Erythrocytes; Flow Cytometry; Fluoresceins; Humans; Hydrogen Peroxide; Kinetics; Oxidation-Reduction; Reactive Oxygen Species; Temperature; Thalassemia | 2003 |
Lysis of red cells from haematological disorders.
Topics: Acetylcysteine; Acute Disease; Anemia, Aplastic; Erythrocytes; Hemolysis; Histological Techniques; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Myeloproliferative Disorders; Thalassemia | 1972 |